SCHEMBL6175028

SCHEMBL6175028

C[C@@]1(Cc2ccnc3ccccc23)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.45

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 18/20 0.45
AR P10275 1/20 0.44
NTRK1 P04629 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173427 1.00 IGF1R (0.45) IGF1RARNTRK1
Trifluoroacetic Acid SCHEMBL17558379 0.95 IGF1R (0.42) IGF1RARNTRK1
SCHEMBL6174389 0.89 IGF1R (0.42) IGF1R
SCHEMBL6173605 0.88 IGF1R (0.45) IGF1RAR
SCHEMBL6176318 0.87 IGF1R (0.42) IGF1RAR
SCHEMBL6174285 0.87 IGF1R (0.46) IGF1RAR
SCHEMBL6174899 0.86 IGF1R (0.45) IGF1R
SCHEMBL6172290 0.86 IGF1R (0.45) IGF1R
SCHEMBL6175290 0.86 IGF1R (0.43) IGF1RNTRK1
SCHEMBL6174017 0.86 IGF1R (0.43) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3188729-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS Genzyme Corporation (US) 2017-07-12 EP disclosed
WO-2016036796-A1 CYCLIC UREA COMPOUNDS AS TROPOMYOSIN-RELATED KINASE (TRK) INHIBITORS GENZYME CORPORATION (US) 2016-03-10 WO disclosed
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed